by bryan | Apr 15, 2019 | Overview & Epidemiology
A study of more than 4,000 young adults found more than 20 percent are walking around with dangerous levels of fat in their liver. This gives them twice the risk of suffering a cardiac event such as a heart attack, and in extreme cases can lead to liver cancer or the...
by bryan | Apr 15, 2019 | Diagnostics & Therapeutic Advancements
On display today at the International Liver Congress are topline results from a proof-of-concept study testing cilofexor (nonsteroidal farnesoid X receptor or FXR agonist) and firsocostat (acetyl-CoA carboxylase or ACC inhibitor). Out of 20 patients who were treated...
by bryan | Apr 15, 2019 | Overview & Epidemiology
Two independent national studies have reported high rates of liver disease progression and mortality among patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH). The studies reported today at The International Liver Congress™ 2019...
Recent Comments